Susquehanna International Group
DNTH icon

Susquehanna International Group’s Dianthus Therapeutics DNTH Stock Holding History

Susquehanna International Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.71M Buy
80,001
+28,535
+55% +$1.65M ﹤0.01% 3738
2025
Q4 		$2.12M Buy
51,466
+39,405
+327% +$1.53M ﹤0.01% 5543
2025
Q3 		$475K Sell
12,061
-18,006
-60% -$460K ﹤0.01% 9081
2025
Q2 		$560K Sell
30,067
-17,311
-37% -$325K ﹤0.01% 8903
2025
Q1 		$859K Buy
47,378
+30,856
+187% +$680K ﹤0.01% 7637
2024
Q4 		$360K Buy
+16,522
New +$425K ﹤0.01% 9418
2024
Q2 		– Sell
-205,487
Closed -$6.16M – 12248
2024
Q1 		$6.16M Buy
205,487
+176,808
+617% +$3.84M ﹤0.01% 3301
2023
Q4 		$298K Buy
+28,679
New +$317K ﹤0.01% 9856
2023
Q3 		– Sell
-6,456
Closed -$78.3K – 12183
2023
Q2 		$78.3K Sell
6,456
-4,888
-43% -$55.6K ﹤0.01% 11115
2023
Q1 		$144K Buy
+11,344
New +$126K ﹤0.01% 10950
2022
Q3 		– Sell
-2,873
Closed -$55K – 13343
2022
Q2 		$55K Buy
+2,873
New +$71K ﹤0.01% 11926
2022
Q1 		– Sell
-652
Closed -$46K – 13155
2021
Q4 		$46K Buy
+652
New +$65.5K ﹤0.01% 12586
2021
Q3 		– Sell
-1,288
Closed -$201K – 12871
2021
Q2 		$201K Sell
1,288
-397
-24% -$72.9K ﹤0.01% 11589
2021
Q1 		$319K Buy
1,685
+775
+85% +$130K ﹤0.01% 10479
2020
Q4 		$114K Sell
910
-289
-24% -$32.8K ﹤0.01% 10432
2020
Q3 		$130K Buy
+1,199
New +$142K ﹤0.01% 9780
2019
Q4 		– Sell
-664
Closed -$109K – 9863
2019
Q3 		$109K Buy
+664
New +$126K ﹤0.01% 9521

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's DNTH Position: Q1 2026 in Review

Susquehanna International Group increased its Dianthus Therapeutics (DNTH) stake by 55% in Q1 2026, buying an estimated $1.65M and bringing the position to 80,001 shares worth $6.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3738.

Susquehanna International Group first reported a position in DNTH in Q3 2019 and has held it in 17 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Susquehanna International Group held 80,001 shares of Dianthus Therapeutics worth $6.71M as of Q1 2026.
  • Susquehanna International Group bought 28,535 Dianthus Therapeutics shares in Q1 2026, an estimated $1.65M.
  • Dianthus Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3738 holding.
  • Susquehanna International Group first reported a position in Dianthus Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.